We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Quantitative Phase Technology Using Silicon Designed to Visualize Cellular Processes

By LabMedica International staff writers
Posted on 16 Oct 2013
A team of scientists has figured out how to quantitatively observe cellular processes taking place on “lab-on-a-chip” devices in a silicon setting.

The new technology should be useful in drug development as well as disease diagnosis, researchers working on the project. More...
In a study published October 2, 2013, in Nature’s online journal Scientific Reports, the investigators reported that it overcame past limitations on quantitative microscopy through an opaque media by working with a new combination of near infrared light and a technique called quantitative phase imaging. The technology is approximately 10-years old and uses shifts in phases of light, not staining techniques, to aid specimen imaging—warranting the term “label-free.”

“To the best of our knowledge, this is the first demonstration of quantitative phase imaging of cellular structure and function in silicon environment,” said Assistant Professor of physics Dr. Samarendra Mohanty, head of the biophysics and physiology laboratory at University of Texas (UT) at Arlington (USA), and corresponding author of the article.

The UT at Arlington and Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) group of scientists was able to study specimens through a silicon wafer in two cases. In one, they achieved full-field imaging of the features of red blood cells to nanometer thickness accuracy. They observed, in another specimen, the dynamic variation of human embryonic kidney cells in response to variations in salt concentration. Dr. Mohanty believes that his group’s current research on near-infrared quantitative-phase imaging can lead to noninvasive, label-free monitoring of neuronal activities.

“Silicon-based microdevices known as labs-on-a-chip are revolutionizing high throughput analysis of cells and molecules for disease diagnosis and screening of drug effects. However, very little progress has been made in the optical characterization of samples in these systems,” said Dr. Bipin Joshi, a recent graduate and lead author of the study. “The technology we’ve developed is well-suited to meet this need.”

Dr. Barman, now an assistant professor at Johns Hopkins University (Baltimore, MD, USA), stated that this study is an excellent example of the type of research he envisages doing, projects driven by needs of the biomedical community and continually pushing the edge of biophotonic technology. “We envision that this significantly expands the visualization possible in silicon based microelectronic and micromechanical devices,” he said.

Related Links:
University of Texas at Arlington
Massachusetts Institute of Technology



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Aliquoting Pipet Controller
ALI-Q 2 Series
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: The partnership with LLS expands access to Lucent’s non-invasive blood-based biomarker tests for early detection of cognitive diseases (photo courtesy of Adobe Stock)

New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network

Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.